Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ANIX

Anixa Biosciences (ANIX) stock: insider trades, news & valuation

Health Care · Strong buying
Close · Oct 9, 2026 $2.90 -0.3% on the day -41.1% over 12 months 52-week range $2.35 – $5.22

Share price and insider trades

ANIX closeInsider buyInsider sale
23456NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $7,487 on 2026-06-16 · Lewis H Titterton Jr.Bought $9,174 on 2026-07-15 · Lewis H Titterton Jr.Bought $11,190 on 2026-07-24 · Amit KumarBought $15,200 on 2026-07-10 · Amit KumarBought $15,620 on 2026-09-30 · Michael CatelaniBought $17,350 on 2026-07-31 · Amit KumarBought $27,944 on 2026-07-27 · Amit KumarBought $30,400 on 2026-01-28 · Arnold M BaskiesBought $33,260 on 2026-09-24 · Amit Kumar, Arnold M BaskiesBought $49,350 on 2026-09-10 · Amit Kumar, Lewis H Titterton Jr.Bought $52,500 on 2026-06-12 · Amit KumarBought $58,940 on 2026-07-20 · Amit Kumar, Lewis H Titterton Jr.Bought $131,907 on 2026-09-23 · Lewis H Titterton Jr.
Bought, 12 months$435K
Sold, 12 months$0
Insiders buying4
Insiders selling0

Anixa Biosciences insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $435K and 0 sold $0 of ANIX stock on the open market, including a cluster buy that began Sep 10, 2026.

ANIX insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $30K bought (1 trades)$30KQ1 2026Q2 2026: $60K bought (2 trades)$60KQ2 2026Q3 2026: $370K bought (15 trades)$370KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$370K15—0
Q2 2026$60K2—0
Q1 2026$30K1—0

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$101MBiotechnology
Profit margin0.0%Revenue growth —
Volume vs. 50-day1.0×Last 5 sessions
Insiders' paper profit+$2KOn all tracked purchases +0.4%

Summary

Over the past 12 months, 4 Anixa Biosciences Inc insiders reported open-market purchases totaling $435K, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Sep 10, 2026, when 3 insiders bought a combined $206K.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 30SEC Michael CatelaniCFO, COO Buy 5,50050,000 held (+12%) $2.84 $16K +2.1% —
Sep 28SEC Amit KumarCEO Buy 7,000672,000 held (+1%) $2.78 $19K +4.3% —
Sep 28SEC Arnold M BaskiesDirector Buy 5,000140,572 held (+4%) $2.76 $14K +5.1% —
Sep 25SEC Lewis H Titterton Jr.Director Buy 49,0361,046,003 held (+5%) $2.69 $132K +7.8% —
Sep 14SEC Lewis H Titterton Jr.Director Buy 10,000996,967 held (+1%) $2.73 $27K +6.2% —
Sep 14SEC Amit KumarCEO Buy 3,000665,000 held (+0%) $2.75 $8K +5.5% —
Sep 11SEC Amit KumarCEO Buy 5,000662,000 held (+1%) $2.76 $14K +5.1% —
Aug 3SEC Amit KumarCEO Buy 5,000657,000 held (+1%) $3.47 $17K -16.4% —
Jul 28SEC Amit KumarCEO Buy 5,000652,000 held (+1%) $3.44 $17K -15.7% —
Jul 27SEC Amit KumarCEO Buy 3,000643,812 held (+0%) $3.73 $11K -22.3% —
Jul 27SEC Amit KumarCEO Buy 3,188647,000 held (+0%) $3.37 $11K -13.9% —
Jul 21SEC Amit KumarCEO Buy 5,000640,812 held (+1%) $3.46 $17K -16.2% —
Jul 20SEC Lewis H Titterton Jr.Director Buy 12,000986,967 held (+1%) $3.47 $42K -16.4% —
Jul 16SEC Lewis H Titterton Jr.Director Buy 2,797974,967 held (+0%) $3.28 $9K -11.6% —
Jul 13SEC Amit KumarCEO Buy 5,000635,812 held (+1%) $3.04 $15K -4.6% —
Jun 17SEC Lewis H Titterton Jr.Director Buy 2,836972,170 held (+0%) $2.64 $7K +9.8% —
Jun 16SEC Amit KumarCEO Buy 21,000630,812 held (+3%) $2.50 $52K +16.0% —
Jan 29SEC Arnold M BaskiesDirector Buy 10,000135,000 held (+8%) $3.04 $30K -4.6% —

Insiders at Anixa Biosciences Inc

InsiderBoughtSoldLast filingScore
Lewis H Titterton Jr.Director $218K — Sep 25, 2026 —
Amit KumarCEO $183K — Sep 28, 2026 —
Arnold M BaskiesDirector $44K — Sep 28, 2026 —
Michael CatelaniCFO, COO $16K — Sep 30, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

ANIX stock: common questions

Are Anixa Biosciences Inc insiders buying ANIX stock?

In the past 12 months, 4 insiders reported open-market purchases of ANIX worth $435K. The latest was CFO, COO Michael Catelani bought $16K of ANIX at $2.84 — first open-market purchase in our records.

Are Anixa Biosciences Inc insiders selling ANIX stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ANIX's 52-week range?

Over the past year ANIX has traded between $2.35 and $5.22. It last closed at $2.90 on Oct 9, 2026.